Story from 24th April, 2018:
In a £1.5m deal, Praetura Ventures (formerly Praetura Capital) invested in UK-based chemical intermediates company Liverpool Chirochem.
Praetura and the Northern Powerhouse Investment Fund led the round, with support from Deepbridge Capital. Praetura Group CEO Mike Fletcher joined the board as a Non-Executive Director.
Liverpool Chirochem raised the money to fund expansion in the UK and construction of a new facility in the China Medical City Science Park, Taizhou, China.
This round leads to a total of £2.6m raised by LCC since 2015, through VC and Angel Investors.
Read more on FinSMEs: “Liverpool Chirochem raises £1.5m in Funding“